Sonoma Pharmaceuticals (SNOA) Short Interest Ratio & Short Volume → The #1 lithium battery stock to have on your radar in 2024! (From Smallcaps Daily) (Ad) Free SNOA Stock Alerts $0.15 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Sonoma Pharmaceuticals Short Interest DataCurrent Short Volume214,200 sharesPrevious Short Volume30,400 sharesChange Vs. Previous Month+604.61%Dollar Volume Sold Short$34,571.88Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares15,610,000 sharesPercentage of Shares Shorted1.37%Today's Trading Volume191,551 sharesAverage Trading Volume1,484,148 sharesToday's Volume Vs. Average13% Short Selling Sonoma Pharmaceuticals ? Sign up to receive the latest short interest report for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNOA Short Interest Over TimeSNOA Days to Cover Over TimeSNOA Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Sonoma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024214,200 shares $34,571.88 +604.6%N/A0.2 $0.16 3/31/202430,400 shares $5,055.52 -74.2%N/A0 $0.17 3/15/2024117,800 shares $16,173.94 -3.1%N/A0.1 $0.14 2/29/2024121,500 shares $17,860.50 +21.3%N/A0.1 $0.15 2/15/2024100,200 shares $15,621.18 -21.2%N/A0 $0.16 1/31/2024127,200 shares $23,544.72 -81.2%N/A0.1 $0.19 Get the Latest News and Ratings for SNOA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024675,100 shares $124,623.46 +238.2%N/A0.4 $0.18 12/31/2023199,600 shares $36,007.84 -48.3%N/A0.2 $0.18 12/15/2023386,000 shares $55,931.40 +348.3%N/A0.4 $0.14 11/30/202386,100 shares $15,222.48 +13.4%N/A0.1 $0.18 11/15/202375,900 shares $12,614.58 +56.2%N/A0.3 $0.17 10/31/202348,600 shares $7,946.10 +17.1%N/A0.3 $0.16 10/15/202341,500 shares $31,955.00 +15.9%N/A1.6 $0.77 9/30/202335,800 shares $27,634.02 -28.1%N/A1.6 $0.77 9/15/202349,800 shares $47,200.44 +16.6%N/A2.1 $0.95 8/31/202342,700 shares $37,255.75 +42.3%N/A0.1 $0.87 8/15/202330,000 shares $27,600.00 -19.8%N/A0.1 $0.92 7/31/202337,400 shares $40,392.00 -29.6%N/A0.1 $1.08 7/15/202353,100 shares $61,065.00 -35.3%N/A0.1 $1.15 6/30/202382,100 shares $87,847.00 -71.5%N/A0.2 $1.07 6/15/2023287,700 shares $376,887.00 +251.7%N/A0.5 $1.31 5/31/202381,800 shares $78,528.00 +7.8%N/A0.1 $0.96 5/15/202375,900 shares $76,218.78 -40.1%N/A0.4 $1.00 4/30/2023126,600 shares $120,054.78 -24.2%N/A0.7 $0.95 4/15/2023167,100 shares $162,087.00 -25.1%N/A0.1 $0.97 3/31/2023223,100 shares $217,812.53 +50.6%N/A0.1 $0.98 3/15/2023148,100 shares $146,663.43 +58.6%N/A0.1 $0.99 2/28/202393,400 shares $113,948.00 -15.0%N/A0.1 $1.22 2/15/2023109,900 shares $168,147.00 -76.5%N/A0.1 $1.53 1/31/2023466,700 shares $774,722.00 +856.4%N/A0.3 $1.66 1/15/202348,800 shares $61,000.00 -4.7%N/A0 $1.25 12/30/202251,200 shares $57,344.00 -46.1%N/A0.1 $1.12 12/15/202295,000 shares $132,050.00 -1.0%N/A0.1 $1.39 11/30/202296,000 shares $164,160.00 -36.6%N/A0.1 $1.71 11/15/2022151,400 shares $337,622.00 +1,974.0%N/A0.2 $2.23 10/31/20227,300 shares $14,527.00 +942.9%N/A0 $1.99 10/15/2022700 shares $1,330.00 -22.2%N/A0 $1.90 9/30/2022900 shares $1,917.00 -84.8%N/A0 $2.13 9/15/20225,900 shares $17,641.00 -19.2%N/A0.1 $2.99 8/31/20227,300 shares $20,294.00 -47.1%N/A0.1 $2.78The Next Nvidia? (Ad)The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. SNOA Short Interest - Frequently Asked Questions What is Sonoma Pharmaceuticals' current short interest? Short interest is the volume of Sonoma Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 214,200 shares of SNOA short. Learn More on Sonoma Pharmaceuticals' current short interest. Is Sonoma Pharmaceuticals' short interest increasing or decreasing? Sonoma Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 214,200 shares, an increase of 604.6% from the previous total of 30,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sonoma Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sonoma Pharmaceuticals: Altamira Therapeutics Ltd. (3.87%), Allarity Therapeutics, Inc. (24.95%), CohBar, Inc. (0.59%), Salarius Pharmaceuticals, Inc. (2.60%), Mustang Bio, Inc. (1.84%), Onconetix, Inc. (2.87%), 60 Degrees Pharmaceuticals, Inc. (1.50%), CNS Pharmaceuticals, Inc. (0.23%), Clever Leaves Holdings Inc. (0.61%), Dermata Therapeutics, Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sonoma Pharmaceuticals stock? Short selling SNOA is an investing strategy that aims to generate trading profit from Sonoma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sonoma Pharmaceuticals? A short squeeze for Sonoma Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNOA, which in turn drives the price of the stock up even further. How often is Sonoma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNOA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CYTO Short Interest ALLR Short Interest CWBR Short Interest SLRX Short Interest MBIO Short Interest ONCO Short Interest SXTP Short Interest CNSP Short Interest CLVR Short Interest DRMA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNOA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024Altimetry[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings